Colin Sandercock is CLO & VP +1 at Cue Biopharma, Inc. (CUE). They have made 4 open-market trades across 1 company since 2019, most recently 2020-08-05.
CIK 0001724870
2 open-market purchases totalling $371K since 2019, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CUE | 30,499 | $518K |
Shares reported on the most recent Form 4, priced at the 2020-08-10 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.